.jpg)
October 22, 2024 – BackStop Neural is proud to acknowledge the significant contributions of Pedro Rocha, PhD, during his tenure at The University of Texas at Dallas. Dr. Rocha, now a Senior Product Engineer at BackStop Neural, played a pivotal role in advancing the field of flexible bioelectronics for neural interfaces.
Dr. Rocha's work, recently published in the Materials Research Society (MRS Communications) 50th Anniversary Research Letter, is titled "Softening and flexible hybrid electronics integration for biomedical applications." The paper highlights three innovative methods for connecting neural stimulation, recording, and modulation technologies to thin film softening bioelectronic devices. These devices, developed on thiol-based shape memory polymers (SMPs) using photolithographic techniques, feature gold traces and high charge injection capacity titanium nitride (TiN) electrodes.
The research, conducted during Dr. Rocha's doctoral studies at UT Dallas, demonstrated cathodal charge storage capacities exceeding 8 mC/cm² and maintained average impedances below 1 kΩ at 1 kHz for each interconnect technique. These advancements were achieved through surface mounting, ultra-thin chips (UTC), and through-hole substrate etching methods.
"This work represents a significant step forward in biomedical applications, offering improved charge storage capacity and electrochemical performance," said BackStop Neural CEO Connie Manz. "We are immensely proud of Dr. Rocha's dedication and his contributions to advancing healthcare technology."
Dr. Rocha's research has the potential to revolutionize neural interfaces, paving the way for more effective and less invasive medical devices. His innovative approach to integrating neural technologies with bioelectronic devices is a testament to his expertise and commitment to improving patient outcomes.
“These discoveries have the potential to significantly improve spinal cord stimulation for both chronic pain relief and motor recovery," said Dr. Rocha. "By integrating softening hybrid electronics with neural interfaces, we are developing devices that are ten times thinner than current electrode arrays. These softening devices interact seamlessly with the body while maintaining high electrical stability and compatibility—critical factors for the future of implantable bioelectronics. Our advancements in high charge storage capacity and low impedance enable more precise and efficient stimulation, potentially improving outcomes for patients suffering from chronic pain or motor impairments.”
At BackStop Neural, Dr. Rocha continues to leverage his extensive background in mechatronics, materials science, bioengineering, and microfabrication to develop cutting-edge medical devices. His work exemplifies the company's mission to push the boundaries of neural technology and enhance the quality of life for patients through innovative solutions.
For more information on BackStop Neural and its groundbreaking work in neural interface technologies, please visit www.backstopneural.com.
About BackStop Neural
BackStop Neural is a pioneering medical device company that specializes in developing advanced spinal cord stimulation solutions for individuals suffering from chronic pain. Through proprietary materials and neurostimulation technology, the company strives to provide patients with a renewed sense of hope and freedom from debilitating conditions. With a team of dedicated experts and a patient-centered approach, BackStop Neural aims to transform the landscape of neurology and elevate the standard of patient care.
For media inquiries, please contact:
Kial Gramley, Chief Product Officer
(956) 219-6752
Σχόλια